Δ9-Tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors
- 1 April 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 371 (2-3) , 187-196
- https://doi.org/10.1016/s0014-2999(99)00165-x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Cannabinoid modulation of intestinal propulsion in miceEuropean Journal of Pharmacology, 1998
- Cannabinoid receptors and their endogenous agonist, anandamide.Neurochemical Research, 1998
- Electrical stimulation of nucleus tractus solitarius excites vagal preganglionic cardiomotor neurons of the nucleus ambiguus in ratsBrain Research, 1992
- Cardiovascular effects of Δ9- andΔ9(11)-tetrahydrocannabinol and their interaction with epinephrineLife Sciences, 1987
- Effects of Acute and Long-Term Cannabis Treatment on Restraint-Induced Gastric Ulceration in RatsThe Japanese Journal of Pharmacology, 1978
- Cardiopulmonary toxicity of Δ9-tetrahydrocannabinol in the anesthetized dogToxicology and Applied Pharmacology, 1975
- The effect of (−)-Δ9-trans-tetrahydrocannabinol on myocardial contractility and venous return in anesthetized dogsEuropean Journal of Pharmacology, 1974
- Interaction of Δ9-tetrahydrocannabinol and cannabidiol on intestinal motility in miceJournal of Pharmacy and Pharmacology, 1974
- The effect of cannabinoids on intestinal motility and their antinociceptive effect in miceBritish Journal of Pharmacology, 1973
- Studies on the bradycardia induced by (−)-Δ9-trans-tetrahydrocannabinol in anesthetized dogsEuropean Journal of Pharmacology, 1973